✨ Medicines Distribution Consents
NEW ZEALAND GAZETTE
No. 107
Health
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Budesonide 50 µg/dose, 100 µg/dose, 200 µg/dose | Inhaler, aerosol, metered | Ingelheim Pharmaceuticals Pty Limited, Pretoria, South Africa | Inflammide |
| Piperacillin sodium 1.04 g, 2.08 g, 4.16 g equivalent to 1 g, 2 g, 4 g piperacillin | Injection, powder | Istituto Biochimico Italiano, Aprilia (LT), Italy | Piperacillin |
Dated this 28th day of July 1998.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go5419
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Sodium valproate 100 mg | Tablet | Sanofi Winthrop Limited, Fawdon, Newcastle-upon-Tyne, United Kingdom | Epilim 100 |
| Sodium valproate 200 mg, 500 mg | Tablets, modified release | Sanofi Winthrop Limited, Fawdon, Newcastle-upon-Tyne, United Kingdom | Crushable Epilim EC |
| Sodium valproate 40 mg/mL | Solution, oral | Sanofi Winthrop Limited, Fawdon, Newcastle-upon-Tyne, United Kingdom; Universal Products (Lytham) Manufacturing Limited, Greenhalgh, Kirkham, Preston, Lancashire, United Kingdom and Sanofi Winthrop Industrie, Colomiers, France | Epilim Liquid |
| Sodium valproate 40 mg/mL | Syrup | Sanofi Winthrop Limited, Fawdon, Newcastle-upon-Tyne, United Kingdom; Universal Products (Lytham) Manufacturing Limited, Greenhalgh, Kirkham, Preston, Lancashire, United Kingdom and Sanofi Winthrop Industrie, Colomiers, France | Epilim Syrup |
| Oestradiol 1.6 mg (25 µg/24 hours), 3.2 mg (50 µg/24 hours), 4.8 mg (75 µg/24 hours), 6.4 mg (100 µg/24 hours) | Transdermal patch | Lohmann Therapie Systeme GmbH & Co KG., Andernach, Germany | Evorel |
| Omeprazole 10 mg, 20 mg | Capsules | Astra Pharmaceutical Production AB., Södertälje, Sweden | Losec |
| Enalapril maleate 2.5 mg, 5 mg, 10 mg, 20 mg | Wafers | R P Scherer Limited, Blagrove, Swindon, Wiltshire, United Kingdom | Renitec RPD |
| Somatropin 24 IU | Injection, powder with diluent | Serono Pharma SpA., Bari, Italy; Diluent (cartridge): Laboratoire Aguettant, Champagne, France; Diluent (vial): Laboratoires Serono SA., Aubonne, Switzerland | Saizen 24 |
| Paclitaxel 6 mg/mL | Infusion, concentrate | Bristol Caribbean Inc., Mayaguez, Puerto Rico | Taxol |
| Interferon alpha 1.3 MIU/mL, 10 MIU/mL | Injection, solution | Glaxo Wellcome Research & Development, Beckenham, Kent, United Kingdom | Wellferon |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1998, No 107
NZLII —
NZ Gazette 1998, No 107
✨ LLM interpretation of page content
🏥 Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare28 July 1998
Medicines, Distribution, Consent, New Medicine, Budesonide, Piperacillin
- G. R. Boyd, Chief Advisor, Regulation and Safety
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social Welfare28 July 1998
Medicines, Distribution, Consent, Changed Medicines, Sodium valproate, Oestradiol, Omeprazole, Enalapril maleate, Somatropin, Paclitaxel, Interferon alpha
- G. R. Boyd, Chief Advisor, Regulation and Safety